These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7687555)

  • 1. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index.
    Fowler FJ; Barry MJ
    Eur Urol; 1993; 24 Suppl 1():24-7. PubMed ID: 7687555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.
    Barry MJ; Fowler FJ; O'Leary MP; Bruskewitz RC; Holtgrewe HL; Mebust WK
    Med Care; 1995 Apr; 33(4 Suppl):AS145-55. PubMed ID: 7536866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
    Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
    Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
    Ertel P; Adalig B; Demircan I; Lartey B; Manyak MJ
    Int J Clin Pract; 2016 Oct; 70(10):870-880. PubMed ID: 27774780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients.
    Eri LM; Tveter KJ
    Eur Urol; 1992; 21(4):257-62. PubMed ID: 1281101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General Practice.
    Lukacs B; McCarthy C; Grange JC
    Eur Urol; 1993; 24 Suppl 1():34-40. PubMed ID: 7687557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a new quality of life questionnaire for benign prostatic hyperplasia.
    Epstein RS; Deverka PA; Chute CG; Panser L; Oesterling JE; Lieber MM; Schwartz S; Patrick D
    J Clin Epidemiol; 1992 Dec; 45(12):1431-45. PubMed ID: 1281223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of benign prostatic hyperplasia among men in Japan: Patient-reported outcomes among those diagnosed and experiencing symptoms.
    Yoshida M; Flores NM; Vietri J; Lee M; Murakami M
    Int J Urol; 2015 Oct; 22(10):949-55. PubMed ID: 26138017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linguistic adaptation and validation of the Spanish version of the Benign Prostatic Hyperplasia-Patient Impact Measure (BPH-PIM).
    Llorente C; Ruiz M; Rejas Gutiérrez J; Esteban M; Villasante F; Hareendran A
    Clin Drug Investig; 2006; 26(2):103-12. PubMed ID: 17163240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques.
    Mozes B; Cohen YC; Olmer L; Shabtai E
    J Urol; 1996 Jan; 155(1):191-6. PubMed ID: 7490831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia.
    Liu CC; Wang CJ; Huang SP; Chou YH; Wu WJ; Huang CH
    Kaohsiung J Med Sci; 2004 Jun; 20(6):273-8. PubMed ID: 15253468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the BSP-BPH (Bononian Satisfaction Profile--Benign Prostatic Hyperplasia) a "disease-specific" questionnaire for the evaluation of health related quality of life in patients with benign prostatic hyperplasia.
    Bertaccini A; Martinelli A; Ceccarelli R; Palmieri F; Vitullo G; Urbinati M; Marchiori D; Costal F; Martorana G
    Arch Ital Urol Androl; 2004 Sep; 76(3):103-9. PubMed ID: 15568297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study.
    Calais Da Silva F; Marquis P; Deschaseaux P; Gineste JL; Cauquil J; Patrick DL
    Eur Urol; 1997; 31(3):272-80. PubMed ID: 9129915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and sexuality: methodological aspects.
    O'Leary MP
    Eur Urol; 2001; 40 Suppl 3():13-8. PubMed ID: 11786672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General Practice.
    Lukacs B; Comet D; Grange JC; Thibault P
    Br J Urol; 1997 Nov; 80(5):722-30. PubMed ID: 9393292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.